Article Information
History
- December 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jonas Ghouse1,2,*,
- Gustav Ahlberg1,2,
- Laura Andreasen1,2,
- Karina Banasik3,
- Søren Brunak3,
- Michael Schwinn4,
- Ina Holst Larsen4,
- Oscar Petersen4,
- Erik Sørensen4,
- Henrik Ullum4,
- Eva Rye Rasmussen5,
- Niclas Eriksson6,
- Pär Hallberg6,
- Mia Wadelius6,
- Henning Bundgaard7 and
- Morten S. Olesen1,2
- 1Laboratory for Molecular Cardiology, Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
- 2Laboratory for Molecular Cardiology, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
- 3Translational Disease Systems Biology, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 4Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
- 5Department of Otorhinolaryngology, Head & Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
- 6Department of Medical Sciences, Clinical Pharmacology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- 7Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
- ↵*Address for correspondence
Jonas Ghouse, MD, Laboratory for Molecular Cardiology, Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Building 9312, Juliane Maries Vej 20, 2100 Copenhagen, Denmark, Tel: +45 35456734, Fax: +45 3545 6500, E-mail: jonasghouse{at}gmail.com
Posted December 11, 2020.
Common variants near the bradykinin receptor B2 gene are associated with angioedema induced by angiotensin-converting-enzyme inhibitor treatment - a genome wide association study
